Switzerland’s most innovative research and development center underscores Roche’s long-term investment in scientific advancement to meet patient needsThe new center will simplify and increase collaboration thereby accelerating scientific innovationGuy Parmelin, Federal Counsel and Head of the Federal Department of Economic Affairs, Education and Research (EAER) will attend the center’s inauguration Basel, 10 September 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the opening of its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel, Switzerland.

瑞士最具创新性的研究与发展中心强调罗氏在科学进步方面的长期投资，以满足患者的需求。新中心将简化并增加合作，从而加速科学创新。联邦法律顾问兼联邦经济事务、教育和研究部（EAER）负责人乌伊·帕梅林将出席该中心2024年9月10日在巴塞尔举行的开幕式。罗氏（SIX:RO，ROG；OTCQX:RHHBY）今天宣布其新的制药研究与早期发展（pRED）中心在瑞士巴塞尔的全球总部开幕。

Equipped with cutting-edge technologies and housing around 1,000 state-of-the-art laboratory and office workplaces, the new center brings together teams of scientists and researchers to accelerate scientific discoveries for patients. Severin Schwan, Chairman of the Roche Group: “Roche has invested CHF 1.2 billion into the new pRED Center, underscoring our ongoing commitment to supporting Switzerland in remaining a leading innovative life sciences hub, the country where Roche was founded over 125 years ago.” Thomas Schinecker, CEO of the Roche Group: “The new pRED Center will play an integral role in collaborating with our research centers across the globe, aiming to boost the effectiveness and efficiency of our R&D, and to deliver the greatest impact for patients.” Hans Clevers, Head of Pharma Research and Early Development (pRED): “By investing in the new center we are continuing to push scientific frontiers to translate innovation into medicines, to better meet the needs of our patients.

新中心拥有尖端技术，拥有约1000个最先进的实验室和办公场所，汇集了科学家和研究人员团队，以加速患者的科学发现。罗氏集团董事长塞维林·施万（Severin Schwan）：“罗氏集团已向新的pRED中心投资12亿瑞士法郎，这突显了我们一直致力于支持瑞士保持领先的创新生命科学中心，罗氏集团在125多年前就在瑞士成立了。”罗氏集团首席执行官托马斯·施内克（Thomas Schinecker）表示：“新的pRED中心将在与我们全球研究中心的合作中发挥不可或缺的作用，旨在提高我们研发的有效性和效率，并为患者带来最大的影响。”药物研究与早期开发（pRED）负责人汉斯·克利弗斯（Hans Clevers）表示：“通过投资新中心，我们将继续推动科学前沿，将创新转化为药物，更好地满足患者的需求。

The new center will enable greater interaction and knowledge sharing across disciplines, for example, chemists, biologists and data scientists.” The new pRED Center consists of two high.

新中心将使化学家、生物学家和数据科学家等学科之间能够进行更大程度的互动和知识共享。”新的pRED中心由两个高。

Attachment

附件

10092024_pRED Center Opening_EN

10092024_pRED中心开业_EN

Get the latest news and updates to your inbox.

在收件箱中获取最新消息和更新。